Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Dr Niall Murphy and Pierre Schwich join Pharnext

They take up the roles of chief scientific officer and chief financial officer

Roche - Basel

Roche boosts cancer portfolio with $1bn Blueprint deal

Collaboration will focus on the development of its ‘immunokinases’ immuno-oncology treatment

- PMLiVE

Valeant shares slide on fears of filing default

Cuts revenue forecasts for 2016 following report of fourth-quarter loss

- PMLiVE

Social media and inflation penalties for generic drugs

US generic drug companies are under more scrutiny as the US public becomes more vocal 

- PMLiVE

Sally Waterman appointed as chair of OBN

She succeeds David Laskow-Pooley

- PMLiVE

Mary Briggs moves from Covance to eClinicalHealth

Becomes head of business development and North American operations

- PMLiVE

Pharma needs to ‘better articulate’ its value to society

And that includes its need to finance new medical discoveries by making a profit

- PMLiVE

FDA allows accelerated review for rivals to over-priced drugs

Aims to combat growing trend in exploitation of sole-source drug pricing

- PMLiVE

GW ascendant as epilepsy drug clears phase III trial

Epidiolex proves effective in controlling seizures in children with Dravet syndrome

- PMLiVE

Focus on multiple myeloma treatment: Witnessing a transformation

Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.

Blue Latitude Health

- PMLiVE

NeuroVive appoints new chief executive officer

Erik Kinnman succeeds Jan Nilsson

- PMLiVE

Building the capabilities for a new ‘patient access’ model

Equipping employees for purpose-driven performance

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links